MAMMARY-TUMOR SUPPRESSION BY TRANSFORMING GROWTH-FACTOR-BETA-1 TRANSGENE EXPRESSION
MAMMARY-TUMOR SUPPRESSION BY TRANSFORMING GROWTH-FACTOR-BETA-1 TRANSGENE EXPRESSION
复制标题
DOI:
10.1073/pnas.92.10.4254
复制
发表时间:
1995-05-09
影响因子:
11.1
通讯作者:
MOSES, HL
中科院分区:
文献类型:
--
作者:
PIERCE, DF;GORSKA, AE;MOSES, HL
In cell culture, type alpha transforming growth factor (TGF-alpha) stimulates epithelial cell growth,whereas TGF-beta 1 overrides this stimulatory effect and is growth inhibitory. Transgenic mice that overexpress TGF-cu under control of the mouse mammary tumor virus (MMTV) promoter/enhancer exhibit mammary ductal hyperplasia and stochastic development of mammary carcinomas, a process that can be accelerated by administration of the chemical carcinogen 7,12-dimethylbenz[a]anthracene. MR4TV-TGF-beta 1 transgenic mice display mammary ductal hypoplasia and do not develop mammary tumors. We report that in crossbreeding experiments involving the production of mice carrying both the MMTV-TGF-beta 1 and MMTV-TGF-alpha transgenes, there is marked suppression of mammary tumor formation and that MMTV-TGF-beta 1 transgenic mice are resistant to 7,12-dimethylbenz [a] anthracene-induced mammary tumor formation. These data demonstrate that overexpression of TGF-beta 1 in vivo can markedly suppress mammary tumor development.